AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $220,143,000 | +111.2% | 3,678,864 | -0.9% | 0.01% | +100.0% |
| Q3 2019 | $104,236,000 | -17.4% | 3,710,815 | +11.3% | 0.00% | -20.0% |
| Q2 2019 | $126,204,000 | +10.8% | 3,333,445 | +14.2% | 0.01% | 0.0% |
| Q1 2019 | $113,927,000 | +79.6% | 2,919,677 | -1.8% | 0.01% | +66.7% |
| Q4 2018 | $63,418,000 | -37.6% | 2,974,591 | +15.8% | 0.00% | -25.0% |
| Q3 2018 | $101,667,000 | +8.2% | 2,567,986 | +4.5% | 0.00% | 0.0% |
| Q2 2018 | $93,925,000 | +59.4% | 2,458,171 | +25.4% | 0.00% | +33.3% |
| Q1 2018 | $58,910,000 | +38.8% | 1,960,404 | +44.3% | 0.00% | +50.0% |
| Q4 2017 | $42,452,000 | +26.3% | 1,358,498 | +13.2% | 0.00% | 0.0% |
| Q3 2017 | $33,609,000 | +22.6% | 1,199,922 | -16.3% | 0.00% | +100.0% |
| Q2 2017 | $27,409,000 | +81.6% | 1,432,788 | +61.8% | 0.00% | 0.0% |
| Q1 2017 | $15,095,000 | +2711.0% | 885,766 | +2916.0% | 0.00% | 0.0% |
| Q4 2016 | $537,000 | +3.5% | 29,369 | +0.7% | 0.00% | 0.0% |
| Q3 2016 | $519,000 | – | 29,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |